Created at	Source	Raw Value	Validated value
Jan. 26, 2022, 10:48 a.m.	usa	GMT of neutralizing antibodies against live SARS-CoV-2 virus on day 28 after the booster dose in immunogenicity cohort.;Incidence of adverse reactions within 28 days after the booster dose.	GMT of neutralizing antibodies against live SARS-CoV-2 virus on day 28 after the booster dose in immunogenicity cohort.;Incidence of adverse reactions within 28 days after the booster dose.